Globus Medical Inc vs Johnson & Johnson
GMED vs JNJ — side-by-side comparison from reported financials. GMED leads 3, JNJ leads 6 of 9 comparable metrics.
Globus Medical Inc
GMED · Healthcare
$74.10+1.05%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | GMED | JNJ |
|---|---|---|
| Price | $74.10 | $261.79 |
| Market cap | $9.95B | $631B |
| Revenue (TTM) | $3.14B | $97.9B |
| Revenue growth | +42.2% | +5.6% |
| Net margin | 17.0% | 21.5% |
| Free cash flow | $756M | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | +24.3% | +37.0% |
| P/E | 18.7 | 29.9 |
| P/E vs own history (cheap-side %) | 98% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 12% | 26% |
| Altman Z-score | 9.56 | — |
| CV checks passed | 9 of 10 | 10 of 10 |
| Employees | 6,000 | 140,800 |
Full résumé-style profiles: GMED CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.